Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2003
08/19/2003US6607884 Oligonucleotide probes; hybridization; polynucleotides; use for modulating muscle cell and adipose tissue growth and detection of cell proliferative disorder of muscle, nerve or fat tissues
08/19/2003US6607880 Methods and reagents for modulating apoptosis
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003US6607729 Surface antigen
08/19/2003US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection
08/19/2003US6607726 Human tumor necrosis factor receptor TR10
08/19/2003CA2165953C Prostaglandin receptor ep3 and dna encoding it
08/19/2003CA2142819C Glucagon receptors
08/19/2003CA2122613C Targeted delivery of virus vector to mammalian cells
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066891A2 Genetic markers for the diagnosis of the expression of inverted nipples in pets, breeding animals and domestic cattle
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066855A1 Swine rag-1 gene and utilization thereof
08/14/2003WO2003066848A1 Porcine fgl2
08/14/2003WO2003066830A2 Human monoclonal antibodies against membrane proteins
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066677A1 Egf/egfr complex
08/14/2003WO2003066675A1 Gene conferring resistance to phytophthora infestans (late-blight) in solanacea
08/14/2003WO2003066662A2 Protein purification
08/14/2003WO2003066661A2 Human dr4 antibodies and uses thereof
08/14/2003WO2003066660A2 A PAIR OF ANTIBODY Fv FRAGMENTS STABILIZED BY COILED­COIL PEPTIDES
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066079A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003WO2003065998A2 Immunoglobulin purification
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065981A2 Therapeutic use for lp229, in particular for wound healing
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003040342A3 Method for generation of modular polynucleotides using solid supports
08/14/2003WO2003039327A3 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003020765A3 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003002713A3 Antibodies to opgl
08/14/2003WO2003001884A3 Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer
08/14/2003WO2002085924A3 ANTI-α3(IV)NC1 MONOCLONAL ANTIBODIES AND ANIMAL MODEL FOR HUMAN ANTI-GLOMERULAR BASEMENT MEMBRANE AUTOANTIBODY DISEASE
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002055735A3 Compositions and methods relating to prostate specific genes and proteins
08/14/2003WO2002055560A3 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
08/14/2003WO2002051439A3 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002048193A3 Camelidae antibody arrays
08/14/2003WO2002046415A3 Polynucleotide and polypeptide sequences of putative transporters and ion channells
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002026779A3 A fibrin/fibrinogen-binding conjugate
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2001098539A3 Gene markers for lung cancer
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030153735 Protein purification
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153731 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153518 Activation and inhibition of the immune system
08/14/2003US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153048 Novel proteins and methods for producing the proteins
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153043 Method for the production of non-immunogenic proteins
08/14/2003US20030153041 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
08/14/2003US20030153039 Using hybridomas cells; gene expression; monoclonal antibodies
08/14/2003US20030153038 Method for in vitro molecular evolution of antibody function
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153022 Therapy for Staphylococcus infections which are antibiotic resistance
08/14/2003US20030153017 Prostate specific antigen; detection of cancer; immunoassay; using monoclonal or polyclonal antibody
08/14/2003US20030153016 PSCA: prostate stem cell antigen
08/14/2003US20030153003 Growth hormone variants
08/14/2003US20030153000 Genetic engineering; culture product; recovering
08/14/2003US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152966 Purifying immunoglobulins from blood by adding sodium caprylate to precipitate contaminating proteins and lipids, then contacting supernatant with ion exchange resin
08/14/2003US20030152965 HCV core protein sequences
08/14/2003US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/14/2003US20030152935 Comprises hybridization probes; electrophoresis; drug screening
08/14/2003US20030152922 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152913 High throughput screening of antibody libraries against membrane proteins; chemokines; infection inhibition
08/14/2003US20030152582 CTL epitopes from EBV
08/14/2003US20030152579 Controlling biosynthesis of hybrid protein; therapy against Helicobacter infections
08/14/2003US20030152576 Antiinflammatory agents; hepatitis virus; vaccines
08/14/2003US20030152575 Using antiidiotypeic antibodies; anticancer, antitumor antibodies
08/14/2003US20030152572 Blocking production of synoviocytes; antiinflammatory agents; prevent signal transduction
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003US20030152568 Antiproliferatory agents; antitumor agents; mixture of fibroblast growth factor and cytolysis agent
08/14/2003US20030152514 Methods for using anti-MUC18 antibodies
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2476211A1 Immunoglobulin purification
08/14/2003CA2476006A1 Egf/egfr complex
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475066A1 Rhamnose binding protein
1 ... 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 ... 1494